Determinants of Compliance with Pulmonary Tuberculosis Medication
DOI:
https://doi.org/10.12928/dpphj.v18i1.8917Keywords:
Adherence, Family support, Health worker, Pulmonary tuberculosis, TuberculosisAbstract
Background: Tuberculosis is an infectious disease caused by the Mycobacterium tuberculosis bacillus. Basic Health Research data in 2018 showed that the prevalence rate of TB in Indonesia was 4%. Data from Gamping II Health Center with a total of 37 drug-sensitive and drug-resistant cases and a 90% drug compliance rate, there was only 1 DR-TB patient who was not compliant with taking medication. This aims to know the Determinants of Adherence to Taking Pulmonary TB Medication. Methods: This study was conducted in the working area of Gamping II Health Center. This study is an observational analytic study with a cross-sectional approach. Samples were taken by a total sampling method of as many as 37 people. The measuring instrument used a questionnaire. Data were processed and analyzed using the Chi-square test with a significance level of ρ<0.05. Results: This study shows that of the 37 respondents with pulmonary tuberculosis, 22 (59.5%) respondents were compliant with taking medication and 15 (40.5%) respondents were not compliant with taking medication. Analysis using the chi-square test showed that there was a relationship between knowledge (ρ=0.009), family support (ρ=0.022), and health worker support (ρ=0.025), towards compliance with taking medication. While not related to patient motivation and access to health services. Conclusion: Of the three most dominant variables affecting adherence to taking medication is the support of health workers. From knowledge, family support and health worker support have a probability of 32.4% for adherence to taking medication in patients with pulmonary tuberculosis.
References
Harding E. WHO global progress report on tuberculosis elimination. Lancet Respir Med. 2020 Jan;8(1):19. doi: 10.1016/S2213-2600(19)30418-7. Epub 2019 Nov 6. Erratum in: Lancet Respir Med. 2019 Nov 15;: PMID: 31706931.
WHO. Tuberculosis Reports. In Ganeva: World Health Organization; 2020. hal. 1120–1. Doi: https://iris.who.int/bitstream/handle/10665/336069/9789240013131-eng.pdf?sequence=1
WHO. Global Tuberculosis Report 2021. France: World Health Organization; 2021. Doi: https://iris.who.int/bitstream/handle/10665/346387/9789240037021-eng.pdf?sequence=1
Sitaresmi MN, Indraswari BW, Rozanti NM, Sabilatuttaqiyya Z, Wahab A. Health-related quality of life profile of Indonesian children and its determinants: a community-based study. BMC Pediatr. 2022 Feb 22;22(1):103. doi: 10.1186/s12887-022-03161-0. PMID: 35193530; PMCID: PMC8862365.
Peltzer K, Pengpid S. Traditional Health Practitioners in Indonesia: Their Profile, Practice and Treatment Characteristics. Complement Med Res. 2019;26(2):93-100. doi: 10.1159/000494457. Epub 2018 Dec 15. PMID: 30572336.
Sterling TR, Njie G, Zenner D, Cohn DL, Reves R, Ahmed A, Menzies D, Horsburgh CR Jr, Crane CM, Burgos M, LoBue P, Winston CA, Belknap R. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep. 2020 Feb 14;69(1):1-11. doi: 10.15585/mmwr.rr6901a1. PMID: 32053584; PMCID: PMC7041302.
Rahayu SR, Zainafree I, Merzistya ANA, Cahyati WH, Farida E, Wandastuti AD, Isbandi, Wahidah N, Saefurrohim MZ, Islam MAN, Fajri A, Subagja M. Development of the SIKRIBO Mobile Health Application for Active Tuberculosis Case Detection in Semarang, Indonesia. Healthc Inform Res. 2022 Oct;28(4):297-306. doi: 10.4258/hir.2022.28.4.297. Epub 2022 Oct 31. PMID: 36380427; PMCID: PMC9672498.
Saptawati L, Primaningtyas W, Dirgahayu P, Sutanto YS, Wasita B, Suryawati B, Nuryastuti T, Probandari A. Characteristics of clinical isolates of nontuberculous mycobacteria in Java-Indonesia: A multicenter study. PLoS Negl Trop Dis. 2022 Dec 27;16(12):e0011007. doi: 10.1371/journal.pntd.0011007. PMID: 36574422; PMCID: PMC9829163.
Venkatesh U, Sharma A, Srivastava DK, Durga R. Health-related quality of life of multidrug-resistant tuberculosis patients: A study of eastern Uttar Pradesh, India. Indian J Tuberc. 2022 Jul;69(3):347-353. doi: 10.1016/j.ijtb.2021.06.002. Epub 2021 Jun 15. PMID: 35760485.
Varela L, Ortiz J, García PK, Luna L, Fuertes-Bucheli JF, Pacheco R. Factors associated with unsuccessful treatment outcome for tuberculosis in previously treated patients in Cali, Colombia, during the period 2015-2019. Biomedica. 2023 Sep 30;43(3):360-373. English, Spanish. doi: 10.7705/biomedica.6961. PMID: 37871564; PMCID: PMC10631542.
Yuan Y, Jin J, Bi X, Geng H, Li S, Zhou C. Factors associated with refusal of preventive therapy after initial willingness to accept treatment among college students with latent tuberculosis infection in Shandong, China. BMC Infect Dis [Internet]. 2023;23(1):1–8. doi: https://doi.org/10.1186/s12879-023-08005-5
Du L, Chen X, Zhu X, Zhang Y, Wu R, Xu J, et al. Determinants of medication adherence for pulmonary tuberculosis patients during continuation phase in Dalian, Northeast China. Patient Prefer Adherence. 2020;14:1119–28. doi: https://doi.org/10.2147/ppa.s243734
Perwitasari DA, Setiawan D, Nguyen T, Pratiwi A, Rahma Fauziah L, Saebrinah E, et al. Investigating the Relationship between Knowledge and Hepatotoxic Effects with Medication Adherence of TB Patients in Banyumas Regency, Indonesia. Int J Clin Pract. 2022;2022. doi: https://doi.org/10.1155/2022/4044530
Ghozali MT, Murani CT. Relationship between knowledge and medication adherence among patients with tuberculosis: a cross-sectional survey. Bali Med J. 2023;12(1):158–63. doi: https://doi.org/10.15562/bmj.v12i1.3826
Hulu PJ, Pane M, Sitorus MEJ, Manurung K, Sinaga J. Analysis of Drug User Compliance in Tuberculosis Patients on Therapy Successat Puskesmas Medan Deli Medan City year 2022. Sci Midwifery. 2022;10(5):4034–42. doi: https://doi.org/10.35335/midwifery.v10i5.1016
Yani DI, Juniarti N, Lukman M. Factors Related to Complying with Anti-TB Medications Among Drug-Resistant Tuberculosis Patients in Indonesia. Patient Prefer Adherence. 2022;16:3319–27. doi: https://doi.org/10.2147/ppa.s388989
Xia T, Chen J, Rui J, Li J, Guo Y. What affected Chinese parents’ decisions about tuberculosis (TB) treatment: Implications based on a cross-sectional survey. PLoS One [Internet]. 2021;16(1 January):1–11. doi: http://dx.doi.org/10.1371/journal.pone.0245691
Holland AE, Liacos A, McDonald CF, Mahal A, Hill CJ, Lee AL, Burge AT, Moore R, Nicolson C, O'Halloran P, Cox NS, Lahham A, Gillies R. Response to letter to the Editor re 'Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) tool predicts reduction in sedentary time following pulmonary rehabilitation in people with Chronic Obstructive Pulmonary Disease (COPD)'. Physiotherapy. 2020 Mar;106:217-218. doi: 10.1016/j.physio.2019.09.002. Epub 2019 Sep 27. PMID: 31992446.
Sofiana L, Ayu SM, Amelia D, Adiningsih P, Sa’diyah U, Putri N, et al. Medication Adherence of Tuberculosis Patients in Yogyakarta: A Cross Sectional Study. J Heal Educ. 2022;7(2):95–106. doi: https://doi.org/10.15294/jhe.v7i2.60607
Pulungan RM, Permatasari P. Predisposing and Enabling Factors Relationship with Successful Treatment of Pulmonary Tuberculosis (TB). J Kesehat Prima. 2021;15(1):57. doi: https://doi.org/10.32807/jkp.v15i1.634
Arisara G, Az-zahra DNN. Relationship Between Level of Knowledge and Motivation with Anti-Tuberculosis Drugs Adherence in Tuberculosis Patients. Public Heal Sebel April J. 2022;1(2):35–9. doi: https://doi.org/10.35842/jkry.v10i3.750
Susilo S, Yuly P. Analysis Of Drug Compliance In Pulmonary Tb Patients Reviewing From Attitude, Motivation And Family Support. J Keperawatan. 2023;15:133–46. doi: https://doi.org/10.32583/keperawatan.v15i1.671
Mutia MS, Ginting CN. Determinants Of Pulmonary Tuberculosis Patients ’ Cure In The Working Area Of Sei Agul Health Center, Medan West District , Medan City. Internasional Journal of Health and Pharmaceutical. 2021;1:2016–20. doi: https://doi.org/10.51601/ijhp.v3i3.202
Lu J, Xu Y, Li Z, Chen X, Lin H, Zhao Q. Diagnosis and Treatment Pathway of MDR/RR-TB in Taizhou, Zhejiang Province, China. Trop Med Infect Dis. 2023;8(2). doi: https://doi.org/10.3390/tropicalmed8020079
Thamineni R, Peraman R, Chenniah J, Meka G, Munagala AK, Mahalingam VT, Ganesan RM. Level of adherence to anti-tubercular treatment among drug-sensitive tuberculosis patients on a newly introduced daily dose regimen in South India: A cross-sectional study. Trop Med Int Health. 2022 Nov;27(11):1013-1023. doi: 10.1111/tmi.13824. Epub 2022 Oct 31. PMID: 36183194.
Mwai M, Matiangi M, Keraka M, Njuhigu E. Determinants of Treatment Interruption among Pulmonary Tuberculosis Patients in Select Health Facilities in Embu County, Kenya. Int J Curr Asp. 2022;6(2):41–56. doi: https://doi.org/10.35942/ijcab.v6i2.269
Putri RYP, Rico Januar Sitorus, Muhammad Zulkarnain. Determinants Of The Event Of Drug Resistant Tuberculosis In The City Of Palembang In 2021. Sci Midwifery. 2022;10(2):1895–904. doi: https://doi.org/10.35335/midwifery.v10i2.580
Reagan M. Open Access Indonesian Journal of Medical Reviews Diagnosis and Treatment of Gout Arthritis. Open Access Indones J Med Rev. 2022;2(1):174–80. doi: https://doi.org/10.37275/oaijmr.v2i1.152
Mahendra Chouksey, Arya V, Nilima Takhelchangbam. Delay in healthcare seeking, diagnosis, and treatment of patients with tuberculosis: A cross-sectional study. Asian J Med Sci. 2023;14(7):99–104. doi: https://doi.org/10.3126/ajms.v14i7.53407
Chen X, Du L, Wu R, Xu J, Ji H, Zhang Y, et al. The effects of family, society and national policy support on treatment adherence among newly diagnosed tuberculosis patients: A cross-sectional study. BMC Infect Dis. 2020;20(1):1–11. doi: https://doi.org/10.1186/s12879-020-05354-3
Asriwati A, Tristiyana PI. The Determinants of Family Support of Lung TB Patients in Consuming Anti Tuberculosis Medicine in Polonia Health Center Medan. Heal Notions. 2020;4(1):1–6. Doi: https://doi.org/10.33846/hn40101
Nirmal A, Kuzmik A, Sznajder K, Lengerich E, Fredrick NB, Chen M, Hwang W, Patil R, Shaikh B. 'If not for this support, I would have left the treatment!': Qualitative study exploring the role of social support on medication adherence among pulmonary tuberculosis patients in Western India. Glob Public Health. 2022 Aug-Sep;17(9):1945-1957. doi: 10.1080/17441692.2021.1965182. Epub 2021 Aug 29. PMID: 34459366.
Sigala A. Analysis of the Role of Family Support in Treatment Compliance of Pulmonary Tuberculosis Clients. Tropical Health and Medical Research. 2023;5(2):113–9. doi: https://doi.org/10.35916/thmr.v5i2.89
Jang Y-R, Lee M-A. A study of relationships among tuberculosis knowledge, family support, and medication adherence in tuberculosis patients. The Journal of Korean Academic Society of Nursing Education. 2022;28(1):80–90. doi: https://doi.org/10.5977/jkasne.2022.28.1.80
Mariani H, Afriandi I, Setiawati EP, Gondodiputro S, Wiwaha G, Nataprawira HM, et al. Tuberculosis Family Support Training’s (TB FaST) Influence on Encouraging TB Treatment Compliance. Open Public Health J. 2022;15(1):1–9. doi: https://doi.org/10.2174/18749445-v15-e2208041
Parwati NM, Bakta IM, Januraga PP, Wirawan IMA. A health belief model-based motivational interviewing for medication adherence and treatment success in pulmonary tuberculosis patients. Int J Environ Res Public Health. 2021;18(24). doi: https://doi.org/10.3390/ijerph182413238
Zahroh C, Ainiyah N, Sholeha U, Sudiana IK, Yusuf A. A Simple Model for Describing Non-Adherence To Medication in Tuberculosis Patients in a Tropical Area, Indonesia. J Keperawatan Soedirman. 2023;18(1):18–22. doi: https://doi.org/10.20884/1.jks.2023.18.1.6593
Yousaf R, M. Rana S, M.A. Qureshi E, Hanif A, Nargus S, SG. Khan M, et al. Factors Associated with Non-Adherence to Anti-Tuberculosis Treatment Among Patients in Lahore, Pakistan. Int J Curr Res Rev. 2022;14(15):47–53. doi: https://doi.org/10.2139/ssrn.3989857
Patrick O, Mathias T, Laban WB. Factors Associated with Treatment Adherence of Patients on Anti-Tuberculosis Drugs Following Covid-19 Pandemic at Health Facilities of Masaka City, Uganda. Am J Heal Med Nurs Pract [Internet]. 2022;7(7):1–16. doi: https://doi.org/10.47672/ajhmn.1030
Amkongo M, Mitonga HK, Alfeus A, Shipingana LNN, Keendjele T, Eelu H, et al. Factors associated with the unsuccessful TB treatment outcomes in the northern regions of Namibia: a mixed methods study. BMC Infect Dis [Internet]. 2023;23(1):1–10. Tersedia pada: https://doi.org/10.1186/s12879-023-08268-y
Lolong DB, Tobing KL, Perwitasari D, Pangaribuan L, Tejayanti T, S OS. Knowledge and Perceived Stigma Towards Tuberculosis among Tuberculosis Suspect by Gender in Community in Indonesia. Indian J Public Heal Res Dev. 2021;494–500. doi: https://doi.org/10.37506/ijphrd.v12i3.16116
Li J, Pu J, Liu J, Wang Q, Zhang R, Zhang T, et al. Determinants of self-management behaviors among pulmonary tuberculosis patients: a path analysis. Infect Dis Poverty [Internet]. 2021;10(1):1–12. doi: https://doi.org/10.1186/s40249-021-00888-3
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Universitas Ahmad Dahlan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors transfer the copyright and grant the Disease Prevention and Public Health Journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) the work for any purpose, even commercially with an acknowledgement of the work's authorship and initial publication in Disease Prevention and Public Health Journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Disease Prevention and Public Health Journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
